- Home
- CPOP vs LTRN Comparison
CPOP vs LTRN Comparison
Compare CPOP & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPOP | LTRN |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6M | 22.2M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CPOP | LTRN |
|---|---|---|
| Price | $0.31 | $2.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 215.9K | ★ 222.8K |
| Earning Date | 11-17-2025 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $1.11 |
| 52 Week High | $2.60 | $5.74 |
Technical Indicators
Market Signals| Indicator | CPOP | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 46.06 |
| Support Level | $0.30 | $1.96 |
| Resistance Level | $0.36 | $2.41 |
| Average True Range (ATR) | 0.03 | 0.24 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 4.80 | 17.11 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.